{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:35:22Z","timestamp":1787754922528,"version":"build-2784847793"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Bone and Joint Surgery"],"published-print":{"date-parts":[[2019,3,20]]},"abstract":"<jats:title>Update<\/jats:title>\n                  <jats:p>This article was updated on March 24, 2020, because of a previous error. On page 505, in the first paragraph of the \u201cMaterials and Methods\u201d section, the sentence that had read \u201cPatients who underwent revision TJA or simultaneous bilateral TJA and those with missing data related to VTE prophylaxis were excluded\u201d now reads \u201cPatients who underwent revision TJA and those with missing data related to VTE prophylaxis were excluded. A subsequent subanalysis with the exclusion of 154 patients (308 knees) who underwent bilateral procedures demonstrated no differences in the reported outcomes.\u201d<\/jats:p>\n                  <jats:p>An erratum has been published: J Bone Joint Surg Am. 2020 May 6;102(9):e42.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The use of aspirin as prophylaxis against venous thromboembolism (VTE) following total joint arthroplasty (TJA) has increased in popularity; however, the potential cardioprotective effects of aspirin when administered as VTE prophylaxis remain unknown. The present study investigated the influence of VTE prophylaxis, including aspirin, on mortality following TJA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We retrospectively reviewed 31,133 patients who underwent primary TJA from 2000 to 2017. Patient demographics, body mass index, and comorbidities were obtained from an electronic chart query. Patients were allocated into 2 cohorts on the basis of the VTE prophylaxis administered: aspirin (25.9%, 8,061 patients) and non-aspirin (74.1%, 23,072 patients). Mortality was assessed with use of an institutional mortality database that is updated biannually. Univariate and multivariate regression analyses were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The overall mortality rate was 0.2% and 0.6% at 30 days and 1 year after TJA, respectively. The use of aspirin was independently associated with lower risk of death at both 30 days (odds ratio [OR], 0.39; p = 0.020) and 1 year (OR, 0.51; p = 0.004). Patients in the non-aspirin cohort showed 3 times the risk of death at 30 days compared with the aspirin cohort (0.3% compared with 0.1%; p = 0.004), and twice the risk of death at 1 year (0.7% compared with 0.3%; p &lt; 0.001). At 1 year, the primary cause of death in the non-aspirin group was cardiac-related (46 of 23,072, 0.20%). In the aspirin group, the rate of cardiac-related death was almost 5 times lower (3 of 8,061, 0.04%; p = 0.005). Risk factors for mortality at 1 year included higher age (p &lt; 0.001), male sex (p = 0.020), history of congestive heart failure (p = 0.003), cerebrovascular disease (p &lt; 0.001), malignancy (p &lt; 0.001), and history of prior myocardial infarction (p &lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The present study demonstrates that the use of aspirin as prophylaxis against VTE following TJA may reduce the risk of mortality. Given the numerous options available and permitted by the current guidelines, orthopaedic surgeons should be aware of the potential added benefits of aspirin when selecting a VTE-prophylactic agent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Therapeutic\n                      <jats:underline>Level III<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.18.00143","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T14:49:42Z","timestamp":1554475782000},"page":"504-513","source":"Crossref","is-referenced-by-count":50,"title":["The Use of Aspirin for Prophylaxis Against Venous Thromboembolism Decreases Mortality Following Primary Total Joint Arthroplasty"],"prefix":"10.2106","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6684-3401","authenticated-orcid":false,"given":"Alexander J.","family":"Rondon","sequence":"first","affiliation":[{"name":"The Rothman Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7759-1641","authenticated-orcid":false,"given":"Noam","family":"Shohat","sequence":"additional","affiliation":[{"name":"The Rothman Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2015-3162","authenticated-orcid":false,"given":"Timothy L.","family":"Tan","sequence":"additional","affiliation":[{"name":"The Rothman Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0217-4752","authenticated-orcid":false,"given":"Karan","family":"Goswami","sequence":"additional","affiliation":[{"name":"The Rothman Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-6139","authenticated-orcid":false,"given":"Ronald C.","family":"Huang","sequence":"additional","affiliation":[{"name":"Bronx Care Orthopaedics, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6985-5870","authenticated-orcid":false,"given":"Javad","family":"Parvizi","sequence":"additional","affiliation":[{"name":"The Rothman Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"issue":"2","key":"bib1-20230811","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest."},{"issue":"5","key":"bib2-20230811","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1302\/0301-620X.98B5.38070","article-title":"Aspirin - have we had the answer all along?","volume":"98-B","author":"Haddad","year":"2016","journal-title":"Bone Joint J."},{"issue":"7","key":"bib3-20230811","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.2106\/JBJS.I.00511","article-title":"American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty","volume":"91","author":"Johanson","year":"2009","journal-title":"J Bone Joint Surg Am."},{"issue":"1","key":"bib4-20230811","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.arth.2009.07.021","article-title":"Venous thromboembolism: management by American Association of Hip and Knee Surgeons","volume":"25","author":"Markel","year":"2010","journal-title":"J Arthroplasty."},{"issue":"1","key":"bib5-20230811","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13018-016-0456-0","article-title":"Impact of recent guideline changes on aspirin prescribing after knee arthroplasty","volume":"11","author":"Shah","year":"2016","journal-title":"J Orthop Surg Res."},{"issue":"9","key":"bib6-20230811","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arth.2015.07.001","article-title":"Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection","volume":"30","author":"Huang","year":"2015","journal-title":"J Arthroplasty."},{"issue":"2","key":"bib7-20230811","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2106\/JBJS.16.00147","article-title":"Low-dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty: a preliminary analysis","volume":"99","author":"Parvizi","year":"2017","journal-title":"J Bone Joint Surg Am."},{"issue":"6","key":"bib8-20230811","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.arth.2009.06.002","article-title":"Venous thromboembolism prophylaxis after major orthopaedic surgery: a pooled analysis of randomized controlled trials","volume":"24","author":"Brown","year":"2009","journal-title":"J Arthroplasty."},{"issue":"11","key":"bib9-20230811","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/jth.12728","article-title":"Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid","volume":"12","author":"Undas","year":"2014","journal-title":"J Thromb Haemost."},{"issue":"2","key":"bib10-20230811","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11999-013-3135-z","article-title":"Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty?","volume":"472","author":"Raphael","year":"2014","journal-title":"Clin Orthop Relat Res."},{"issue":"11","key":"bib11-20230811","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1302\/0301-620X.99B11.BJJ-2017-0337.R2","article-title":"Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions","volume":"99-B","author":"Azboy","year":"2017","journal-title":"Bone Joint J."},{"issue":"8607","key":"bib12-20230811","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"2","year":"1988","journal-title":"Lancet."},{"issue":"7141","key":"bib13-20230811","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/bmj.316.7141.1337","article-title":"ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"316","author":"Baigent","year":"1998","journal-title":"BMJ."},{"issue":"7329","key":"bib14-20230811","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ."},{"issue":"3","key":"bib15-20230811","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.arth.2012.06.040","article-title":"Risk factors for early mortality following modern total hip arthroplasty","volume":"28","author":"Aynardi","year":"2013","journal-title":"J Arthroplasty."},{"issue":"1","key":"bib16-20230811","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arth.2008.11.010","article-title":"Risk factors for perioperative mortality after lower extremity arthroplasty: a population-based study of 6,901,324 patient discharges","volume":"25","author":"Memtsoudis","year":"2010","journal-title":"J Arthroplasty."},{"issue":"6","key":"bib17-20230811","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1302\/2046-3758.36.2000239","article-title":"Mortality after total hip replacement surgery: A systematic review","volume":"3","author":"Berstock","year":"2014","journal-title":"Bone Joint Res."},{"issue":"9212","key":"bib18-20230811","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial","volume":"355","year":"2000","journal-title":"Lancet."},{"issue":"453","key":"bib19-20230811","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.blo.0000238861.84733.9d","article-title":"Multimodal prophylaxis for THA with mechanical compression","volume":"453","author":"Lachiewicz","year":"2006","journal-title":"Clin Orthop Relat Res."},{"issue":"464","key":"bib20-20230811","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/BLO.0b013e3181468951","article-title":"Mechanical calf compression and aspirin prophylaxis for total knee arthroplasty","volume":"464","author":"Lachiewicz","year":"2007","journal-title":"Clin Orthop Relat Res."},{"issue":"7","key":"bib21-20230811","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.arth.2009.06.021","article-title":"Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?","volume":"25","author":"Bozic","year":"2010","journal-title":"J Arthroplasty."},{"issue":"11","key":"bib22-20230811","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1302\/0301-620X.93B11.27622","article-title":"The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry","volume":"93","author":"Jameson","year":"2011","journal-title":"J Bone Joint Surg Br."},{"issue":"10","key":"bib23-20230811","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00264-012-1588-4","article-title":"Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol","volume":"36","author":"Vulcano","year":"2012","journal-title":"Int Orthop."},{"issue":"7","key":"bib24-20230811","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1302\/0301-620X.94B7.29129","article-title":"The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data","volume":"94","author":"Jameson","year":"2012","journal-title":"J Bone Joint Surg Br."},{"issue":"2","key":"bib25-20230811","first-page":"59","article-title":"Prevention of venous thromboembolism after total joint arthroplasty: aspirin is enough for most patients","volume":"44","author":"Dalury","year":"2015","journal-title":"Am J Orthop (Belle Mead NJ)."},{"issue":"8","key":"bib26-20230811","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1302\/0301-620X.98B8.36957","article-title":"Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty","volume":"98-B","author":"Wilson","year":"2016","journal-title":"Bone Joint J."},{"issue":"9","key":"bib27-20230811","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.arth.2016.02.074","article-title":"Aspirin is as effective as and safer than warfarin for patients at higher risk of venous thromboembolism undergoing total joint arthroplasty","volume":"31","author":"Huang","year":"2016","journal-title":"J Arthroplasty."},{"issue":"1","key":"bib28-20230811","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2106\/00004623-200701000-00005","article-title":"Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty","volume":"89","author":"Patel","year":"2007","journal-title":"J Bone Joint Surg Am."},{"issue":"9","key":"bib29-20230811","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.arth.2015.04.048","article-title":"Direct costs of aspirin versus warfarin for venous thromboembolism prophylaxis after total knee or hip arthroplasty","volume":"30","author":"Gutowski","year":"2015","journal-title":"J Arthroplasty."},{"issue":"2","key":"bib30-20230811","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.arth.2014.08.018","article-title":"Cost-effective prophylaxis against venous thromboembolism after total joint arthroplasty: warfarin versus aspirin","volume":"30","author":"Mostafavi Tabatabaee","year":"2015","journal-title":"J Arthroplasty."},{"issue":"2","key":"bib31-20230811","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2036.1994.tb00271.x","article-title":"Review article: aspirin and gastrointestinal bleeding","volume":"8","author":"Hawkey","year":"1994","journal-title":"Aliment Pharmacol Ther."},{"issue":"6","key":"bib32-20230811","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/ALN.0000000000001352","article-title":"Perioperative aspirin for prevention of venous thromboembolism: the PeriOperative ISchemia Evaluation-2 Trial and a pooled analysis of the randomized trials","volume":"125","author":"Eikelboom","year":"2016","journal-title":"Anesthesiology."},{"key":"bib33-20230811","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7812\/TPP\/16-171","article-title":"Mortality after total knee and total hip arthroplasty in a large integrated health care system","volume":"21","author":"Inacio","year":"2017","journal-title":"Perm J."},{"issue":"3","key":"bib34-20230811","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1054\/arth.2002.30774","article-title":"Causes of death after total hip arthroplasty: a nationwide cohort study with 24,638 patients","volume":"17","author":"Paavolainen","year":"2002","journal-title":"J Arthroplasty."},{"issue":"2","key":"bib35-20230811","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/1602400205","article-title":"Predictors of mortality in patients with femoral neck fracture","volume":"24","author":"Major","year":"2016","journal-title":"J Orthop Surg (Hong Kong)."},{"issue":"4","key":"bib36-20230811","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jor.2017.08.002","article-title":"Comparison of postoperative complications after total hip arthroplasty among patients receiving aspirin, enoxaparin, warfarin, and factor Xa inhibitors","volume":"14","author":"Agaba","year":"2017","journal-title":"J Orthop."},{"issue":"24","key":"bib37-20230811","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2106\/JBJS.L.00789","article-title":"Periprosthetic joint infection increases the risk of one-year mortality","volume":"95","author":"Zmistowski","year":"2013","journal-title":"J Bone Joint Surg Am."},{"issue":"1","key":"bib38-20230811","doi-asserted-by":"crossref","first-page":"e006694","DOI":"10.1136\/bmjopen-2014-006694","article-title":"A short-term risk-benefit analysis of occasional and regular use of low-dose aspirin in primary prevention of vascular diseases: a nationwide population-based study","volume":"5","author":"Wu","year":"2015","journal-title":"BMJ Open."},{"key":"bib39-20230811","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fimmu.2017.00261","article-title":"Aspirin: the mechanism of action revisited in the context of pregnancy complications","volume":"8","author":"Cadavid","year":"2017","journal-title":"Front Immunol."},{"issue":"6","key":"bib40-20230811","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamaoncol.2015.6396","article-title":"Population-wide impact of long-term use of aspirin and the risk for cancer","volume":"2","author":"Cao","year":"2016","journal-title":"JAMA Oncol."},{"issue":"3","key":"bib41-20230811","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/17453674.2017.1279496","article-title":"Is decreasing mortality in total hip and knee arthroplasty patients dependent on patients\u2019 comorbidity?","volume":"88","author":"Glassou","year":"2017","journal-title":"Acta Orthop."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004623-201903200-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:34:54Z","timestamp":1787751294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004623-201903200-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.18.00143","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,20]]}}}